Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes

New treatment options may lead to an increased interest in using reliable and sensitive instruments assess health-related quality of life people with alopecia areata (AA). The purpose this paper is present current knowledge about assessment AA. dermatology-specific Dermatology Life Quality Index (DLQI) was the most widely reported instrument used Three AA-specific (Alopecia Areata Symptom Impact Scale, Alopecia Patients' Life) three hair disease-specific (Hairdex, Scalpdex ‘hair-specific Skindex-29’) were identified a range content validation characteristics: there little evidence yet actual use these measures best-validated instrument. Further extensive needed for all instruments. European Academy Venereology Task Force on Patient Oriented Outcomes recommends DLQI questionnaire, areata-specific Scale or Index, despite limited experience their use. We hope that new methods will be able improve both clinical signs patients In order outcomes trials methods, it would helpful when further development being encouraged also conducted.